Works matching IS 11707690 AND DT 2009 AND VI 27 AND IP 4

Results: 10

Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines.

Published in:

2009

By:

Siebert U;
Sroczynski G;
Aidelsburger P;
Rossol S;
Wasem J;
Manns MP;
McHutchison JG;
Wong JB;
Siebert, Uwe;
Sroczynski, Gaby;
Aidelsburger, Pamela;
Rossol, Siegbert;
Wasem, Jürgen;
Manns, Michael P;
McHutchison, John G;
Wong, John B

Publication type:

journal article

Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study.

Published in:

2009

By:

Pizzi LT;
Talati A;
Gemmen E;
Dahl NV;
Bunz TJ;
Sand PK;
Pizzi, Laura T;
Talati, Amy;
Gemmen, Eric;
Dahl, Naomi V;
Bunz, Thomas J;
Sand, Peter K

Publication type:

journal article

Cost effectiveness of drug-eluting stents in Belgian practice: healthcare payer perspective.

Published in:

2009

By:

Neyt M;
De Laet C;
De Ridder A;
Van Brabandt H;
Neyt, Mattias;
De Laet, Chris;
De Ridder, Annemieke;
Van Brabandt, Hans

Publication type:

journal article

Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources.

Published in:

2009

By:

Bilcke J;
Beutels P;
Bilcke, Joke;
Beutels, Philippe

Publication type:

journal article

Willingness to Pay for Cancer Prevention.

Published in:

PharmacoEconomics, 2009, v. 27, n. 4, p. 299, doi. 10.2165/00019053-200927040-00003

By:

Hunt, Timothy L.;
Luce, Bryan R.;
Page, Matthew J.;
Pokrzywinski, Robin

Publication type:

Article

Reviewing the Cost Effectiveness of Rotavirus Vaccination.

Published in:

PharmacoEconomics, 2009, v. 27, n. 4, p. 281, doi. 10.2165/00019053-200927040-00002

By:

Bilcke, Joke;
Beutels, Philippe

Publication type:

Article

Impact of Transdermal Oxybutynin on Work Productivity in Patients with Overactive Bladder.

Published in:

PharmacoEconomics, 2009, v. 27, n. 4, p. 329, doi. 10.2165/00019053-200927040-00005

By:

Pizzi, Laura T.;
Talati, Amy;
Gemmen, Eric;
Dahl, Naomi V.;
Bunz, Thomas J.;
Sand, Peter K.

Publication type:

Article

Economic and Human Costs of Restless Legs Syndrome.

Published in:

PharmacoEconomics, 2009, v. 27, n. 4, p. 267, doi. 10.2165/00019053-200927040-00001

By:

Reinhold, Thomas;
Müller-Riemenschneider, Falk;
Willich, Stefan N.;
Brüggenjürgen, Bernd

Publication type:

Article

Cost Effectiveness of Drug-Eluting Stents In Belgian Practice.

Published in:

PharmacoEconomics, 2009, v. 27, n. 4, p. 313, doi. 10.2165/00019053-200927040-00004

By:

Neyt, Mattias;
De Laet, Chris;
De Ridder, Annemieke;
Van Brabandt, Hans

Publication type:

Article

Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response.

Published in:

PharmacoEconomics, 2009, v. 27, n. 4, p. 341, doi. 10.2165/00019053-200927040-00006

By:

Siebert, Uwe;
Sroczynski, Gaby;
Aidelsburger, Pamela;
Rossol, Siegbert;
Wasem, Jürgen;
Manns, Michael P.;
McHutchison, John G.;
Wong, John B.

Publication type:

Article